Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Alzitin-ER 7 Tablet

Prescription Icon
Prescription Required

Marketer

Consern Pharma Limited

Salt Composition

Memantine (7mg)

Overview Alzitin-ER 7 Tablet

For individuals diagnosed with moderate to severe Alzheimer's, Alzitin-ER 7 Tablet offers a therapeutic approach to manage disease progression. Its mechanism involves modulating neurotransmission, thereby enhancing cognitive function and slowing disease advancement. This medication can be administered with or without food, although consistent daily timing is recommended for optimal blood levels. If a dose is missed, take it immediately upon recollection; avoid skipping doses and complete the prescribed regimen regardless of perceived improvement. Abrupt cessation should be avoided; consult your physician before discontinuing treatment. Commonly reported side effects include headache, dizziness, confusion, and constipation. Drowsiness may occur; refrain from driving or activities demanding alertness until the medication's effects are understood. Prior to commencing therapy, disclose any pre-existing conditions, including seizures, kidney, heart, or liver ailments, as well as concurrent medications to your physician. Pregnant or breastfeeding individuals require medical consultation before initiating Alzitin-ER 7 Tablet use.

Primary Ingredients of Alzitin-ER 7 Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Alzitin-ER 7 Tablet

Senile dementia of the Alzheimer type

Major Benefits of Alzitin-ER 7 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Alzitin-ER 7 Tablets can be administered with or without food, though consistent timing is recommended.

Common Side effects of Alzitin-ER 7 Tablet:

  • Dizziness
  • Headache
  • Confusion
  • Constipation

How to use Alzitin-ER 7 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Alzitin-ER 7 Tablets can be administered with or without food, however, consistent timing is recommended.

How Alzitin-ER 7 Tablet works:

Alzitin-ER 7 tablets function as an NMDA receptor antagonist, targeting the overproduction of glutamate—a key neurotransmitter—responsible for memory impairment in Alzheimer's disease. By blocking NMDA receptors, Alzitin-ER 7 regulates glutamate levels, thereby mitigating the disruption of nerve signal transmission and associated memory loss.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Alzitin-ER 7 Tablet with alcohol. Seek medical advice before combining them.

PregnancyPregnancySAFE IF PRESCRIBED

Extended-release Alzitin 7 mg tablets are typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human trials are currently scarce.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Alzitin-ER 7 Tablet with breastfeeding is currently unavailable. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with Alzitin-ER 7 Tablet.

KidneyKidneyCAUTION

For individuals with severe kidney impairment, Alzitin-ER 7 Tablet requires careful administration. Dosage modification of Alzitin-ER 7 Tablet may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should exercise caution when using Alzitin-ER 7 Tablet, potentially requiring dosage modification. Consult a physician for guidance. Data regarding Alzitin-ER 7 Tablet use in such patients is limited. Dosage alteration is not advised for individuals with mild to moderate liver dysfunction.

What if you forget to take Alzitin-ER 7 Tablet :

Omit any missed Alzitin-ER 7 Tablet dose and resume your regular dosing regimen. Avoid taking a double dose.

Facts to Know About Alzitin-ER 7 Tablet

LabelValue
Chemical Category Amantadine Analog
Developing Habits No.
Treatment Category Neuroscience, Central Nervous System
Actions Memantine and Alzheimer's Disease

FAQs on Alzitin-ER 7 Tablet

Alzitin-ER 7 Tablet is not considered to have a potential for abuse; indeed, it may help curb overuse of addictive substances like morphine or alcohol.
Take one Alzitin-ER 7 tablet orally daily, at the same time each day for optimal results. Swallow the tablet with water; it may be taken with or without food.
Alzitin-ER 7 Tablet's full effects may take 3 to 8 hours to become apparent. Your doctor will likely schedule follow-up appointments at four weeks and six months to monitor your progress.
Alzitin-ER 7 Tablet overdose symptoms can manifest as tiredness, weakness, drowsiness, confusion, hallucinations, and vomiting. Additional symptoms may include diarrhea, dizziness, agitation, aggression, and gait disturbances.
Alzitin-ER 7 Tablet, an NMDA receptor antagonist, reduces abnormal brain activity. This may improve cognitive function and slow its decline in Alzheimer's patients. However, its effectiveness diminishes over time, and it does not cure or prevent Alzheimer's disease.
Dementia, a syndrome marked by declining memory, thinking skills, behavior, and daily functioning, is a leading cause of disability and dependence in older adults globally. Alzheimer's disease accounts for approximately 60–70% of dementia cases.
Don't discontinue Alzitin-ER 7 Tablets even if you feel well; it manages, but doesn't cure, Alzheimer's symptoms. Always consult your doctor before stopping this medication.
Drowsiness is a possible side effect of Alzitin-ER 7 Tablet. This medication may moderately impair driving and operating machinery; patients should exercise caution.
Alzitin-ER 7 Tablet can be safely used with donepezil; no heightened adverse effects are anticipated. This combination won't cure Alzheimer's disease, but may improve cognitive function, short-term memory, and related symptoms.
Alzitin-ER 7 Tablet may interact negatively with other medications, potentially reducing its effectiveness or increasing side effects. Always consult your doctor before taking any medication with Alzitin-ER 7 Tablet.
Concurrent use of Alzitin-ER 7 Tablet and hydrochlorothiazide (HCT) may reduce HCT effectiveness due to decreased HCT levels. Conversely, procainamide and quinidine can elevate Alzitin-ER 7 Tablet levels, potentially increasing toxicity.
Continue taking your prescribed Alzitin-ER 7 Tablet, even if you feel better. Discontinuing the medication may cause your dementia symptoms to return.
Alzitin-ER 7 Tablet
119
MRP 145
17% off